metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-83 RELEVANCE OF RENAL CHANGES IN A LARGE SERIES OF SEVERELY OBESE PATIENTS WIT...
Información de la revista
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Open Access
P-83 RELEVANCE OF RENAL CHANGES IN A LARGE SERIES OF SEVERELY OBESE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE
Visitas
497
Kellyane Dias Carvalho, Carla Daltro, Claudia Daltro, Helma P. Cotrim
Nonalcoholic Steatohepatitis Study Group – Medicine School, Federal University of Bahia, CNPQ, Brazil
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 24. Núm S1

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Más datos
Introduction

Metabolic associated fatty liver disease (MAFLD) is the most common cause of chronic liver disease worldwide. Recently, the relationship between MAFLD and chronic kidney disease has raised more interest because this relationship may be an additional factor that interferes with the clinical course and prognosis of this frequent liver disease.

Aim

To evaluate the prevalence and clinical relevance of renal changes in severely obese patients. with MAFLD.

Methodology

A cross-sectional study was conducted with obese patients (BMI > 35 Kg/m²) and MAFLD coming from a surgical treatment of obesity center between 2015 and 2018. MAFLD criteria: presence of steatosis (abdominal ultrasound); in addition to one of the following three criteria, overweight/obesity, type 2 diabetes mellitus (T2DM), and other features of metabolic disfunction. FIB-4 and APRI scores were used to define presence or evaluate liver fibrosis. Glomerular filtration rate was estimated by the CKD-EPI equation and the normal was considered ≥ 90 and <120 mL/min/1,73 m2.

Results

A total of 394 individuals with MAFLD were included. Of these, 279 cases were female (70.8%) with a mean age of 36.8±10 years. Arterial hypertension was observed in 162(41.1%) of the subjects and 66 (16.8 %) had T2DM. Glomerular filtration rate of 60-89 ml/min was observed in 57 (14.5%), 31 of these were not arterial hypertension (54.4%) and 46 (80.7%) did no presented T2DM. Thirteen (3.3%) of the obese cases with MAFLD already had advanced fibrosis.

Conclusion

The results show that severely obese with MAFLD may present renal alterations without other metabolic disfunction. The data also suggest that attention should be given to this complication in the obese patients, that can be the only risk factor to MAFLD.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2023.101122
No mostrar más